Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dementia studies and cohort research

Dementias Platform UK (DPUK) is a public-private partnership funded by the Medical Research Council (MRC) which aims to detect and treat dementia earlier than ever before.

Dementia affects over 50 million people globally and yet to date there are no successful treatments. In 2014 the MRC launched DPUK to revolutionise dementia studies and cohort research, as dementia is the leading cause of death in England and Wales.

DPUK is transforming research through partnering with Universities, the National Institute for Health Research (NIHR) and industry. In addition, DPUK has developed expert technology networks - imaging, stem cell and informatics - that are increasing our understanding of how dementia starts.

The DPUK platform

The DPUK Data Portal

The portal gives researchers rapid online access to unprecedented amounts of cohort data –  genetics, imaging and medical records of over 3 million participants. This is generating new insights into aging, diseases, and dementia risk.

Experimental medicine studies

Studies are breaking new ground using stem cell, imaging, and informatics technologies. This is increasing the scale and rigor of trials and adding to our knowledge of how dementia starts and where to target treatments.

Academic-industry partnerships

By collaborating with industry in a pre-competitive environment, researchers are able to share knowledge, skills and findings that pinpoint which treatments may work in which people.

 

ECR training day

Our values

Dementias Platform UK is:

  • Generous:  We share data, best practice and technologies.
  • Creative: We harness new ideas, new technologies and new ways of working.
  • Collaborative: We invite all stakeholders to join our programmes and shape our activity.
  • Enabling: We facilitate the leverage of further resources for dementia research.

Our partners 

Cambridge

Araclon Biotech
Cardiff
AstraZeneca
GSK Edinburgh Invicro Imperial
Kings College London IXICO Manchester janssen
Somalogic swansea_university_logo UCL Newcastle-University-logo
Oxford wide UniversityofExetercolour_logo.jpg responsive_image.jpg Cognetivity_primary-colour.png